Announced positive initial comparative analytical results, confirming identical amino-acid sequencing and highly similar functional ...
FDA provided constructivefeedback on Company’s analytical similarity strategy under the 351(k) biosimilar pathway Company continues to execute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results